Safety of the Sputnik V Vaccine in Health Personnel of Private Effectors of the City of Buenos Aires, Argentina

NCT04738435 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2021-08-25

No results posted yet for this study

Summary

The main of the study is to describe the incidence in health personnel who present events supposedly attributed to vaccines and immunizations after having received the two components of the Sputnik V vaccine, with the information obtained thanks to the participation of health workers in actively reporting their health status.

Conditions

Sponsors & Collaborators

  • Ministerio de Salud de Ciudad Autónoma de Buenos Aires

    collaborator OTHER_GOV
  • Hospital Italiano de Buenos Aires

    lead OTHER

Principal Investigators

  • Vanina pagotto, Msc · Hospital Italiano de Buenos Aires

  • Silvana Figar, Msc · Hospital Italiano de Buenos Aires

  • Mercedes Soriano · Hospital Italiano de Buenos Aires

  • Analia Ferloni, MD · Hospital Italiano de Buenos Aires

  • Valeria Aliperti, Msc · Hospital Italiano de Buenos Aires

  • Morena Diaz · Hospital Italiano de Buenos Aires

  • Nahuel Braguisnky · Hospital Italiano de Buenos Aires

  • Maria Isabel González · Hospital Italiano de Buenos Aires

  • Maria Ines Staneloni, MD · Hospital Italiano de Buenos Aires

  • Valeria Asprea, MD · Hospital Italiano de Buenos Aires

  • Paula Zingoni, MD · Ministry of Health of the Government of the City of Buenos Aires

  • Hernan Michelangelo, MD · Hospital Italiano de Buenos Aires

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-05
Primary Completion
2021-03-01
Completion
2021-03-01

Countries

  • Argentina

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04738435 on ClinicalTrials.gov